Adiponectin and bone metabolism markers in female rowers: Eumenorrheic and oral contraceptive users

Journal of Endocrinological Investigation

Volumn 34, Issue 11, 2011, Pages 835-839

  Jürimäe, Jaak ^a   Vaiksaar, S ^a   Maestu J ^a   Purge, P ^a   Jurimae T ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Adiponectin; Athletes; Energy homeostasis; Menstrual cycle; Oral contraceptive; Osteocalcin

Indexed keywords

ADIPONECTIN; CARBOXY TERMINAL TELOPEPTIDE; ESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; GLUCOSE; INSULIN; OSTEOCALCIN; PROGESTERONE; TYPE 1 CARBOXYTERMINAL TELOPEPTIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AEROBIC CAPACITY; ARTICLE; BODY COMPOSITION; BONE METABOLISM; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; LOW DRUG DOSE; LUTEAL PHASE; MEASUREMENT; MENSTRUAL CYCLE; ORAL CONTRACEPTION; OSSIFICATION;

ADIPONECTIN; ADIPOSE TISSUE; ADOLESCENT; AMENORRHEA; ATHLETES; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BONE RESORPTION; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; INSULIN RESISTANCE; OSTEOCALCIN; OSTEOGENESIS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84858059561     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7415     Document Type: Article

References (24)

1. Asimakopoulos B, Milousis A, Gioka T, et al. Serum pattern of circulating adipokines throughout the physiological menstrual cycle. Endocr J 2009, 56: 425-33.
2. Gomez-Ambrosi J, Rodriguez A, Catalan V, Frühbeck G. The bone-adipose axis in obesity and weight loss. Obes Surg 2008, 18: 1134-43.
3. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001, 7: 947-53. (Pubitemid 32756433)
4. Dafopoulos K, Sourlas D, Kallitsaris A, Pornaras S, Messinis IE. Blood ghrelin, resistin, and adiponectin concentrations during the normal menstrual cycle. Fertil Steril 2009, 92: 1389-94.
5. Hall N, White C, O'Sullivan AJ. The relationship between adiponectin, progesterone, and temperature across the menstrual cycle. J Endocrinol Invest 2009, 32: 279-83.
6. Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130: 456-69. (Pubitemid 47208519)
7. Vescovi JD, VanHeest JL, De Souza MJ. Short-term response of bone turnover to low-dose oral contraceptives in exercising women with hyothalamic amenorrhea. Contraception 2008, 77: 97-104.
8. Devries MC, Hamadeh MJ, Phillips SM, Tamopolsky MA. Menstrual cycle phase and sex influence muscle glycogen utilization and glucose turnover during moderate-intensity endurance exercise. Am J Physiol Regul Integr Comp Physiol 2006, 291: R1120-8. (Pubitemid 44498454)
9. Suh SH, Casazza GA, Horning MA, Miller BF, Brooks GA. Luteal and follicular glucose fluxes during rest and exercise in 3-h postabsorptive women. J Appl Physiol 2002, 93: 42-50. (Pubitemid 34686191)
10. Jürimäe J. Methods for monitoring training status and their effects on performance in rowing. Int Sport Med J 2008, 9: 11-21.
11. Rechichi C, Dawson B, Goodman C. Oral contraceptive phase has no effect on endurance test. Int J Sports Med 2008, 29: 277-81. (Pubitemid 351542886)
12. Casazza GA, Jacobs KA, Suh SH, Miller BF, Horning MA, Brooks GA. Menstrual cycle phase and oral contraceptive effects on tryglyceride mobilization during exercise. J Appl Physiol 2004, 97: 302-9. (Pubitemid 38802532)
13. Thong FSL, McLean C, Graham TE. Plasma leptin in female athletes: relationship with body fat, reproductive, nutritional, and endocrine factors. J Appl Physiol 2000, 88: 2037-44. (Pubitemid 30453908)
14. Timmons BW, Hamadeh MJ, Devries MC, Tamopolsky MA. Influence of gender, menstrual phase, and oral contraceptive use on immunological changes in response to prolonged cycling. J Appl Physiol 2005, 99: 979-85. (Pubitemid 41214512)
15. Landgren BM, Unden AL, Diczfalusy E. Hormonal profile of the cycle in 68 normally menstruating women. Acta Endocrinol 1980, 94: 89-98. (Pubitemid 10118440)
16. Hofmann P, Jürimäe T, Jürimäe J, et al. HRTP, prolonged ergometer exercise and single sculling. Int J Sports Med 2007, 28: 964-9. (Pubitemid 350144591)
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in men. Diabetologia 1985, 28: 412-9. (Pubitemid 15018832)
18. Russell M, Stark J, Nayak S, et al. Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controls. Bone 2009, 45: 104-9.
19. Chiu KM, Ju J, Mayes D, Bacchetti P, Weitz S, Arnaud CD. Changes in bone resorption during the menstrual cycle. J Bone Miner Res 1999, 14: 609-15. (Pubitemid 29153395)
20. Gorai I, Taguchi Y, Chaki O, et al. Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle. J Clin Endocrinol Metab 1988, 83: 326-32.
21. van der Sluis IM, Hop WC, van Leeuwen JP, Pols HA, de Muinck Keizer-Schrama SM. A cross-sectional study on biochemical parameters of bone turnover and vitamin D metabolites in healthy Dutch children and young adults. Horm Res 2002, 57: 170-9. (Pubitemid 34621648)
22. Jürimäe J, Purge P, Jürimäe T. Adiponectin and stress hormone responses to maximal sculling after volume-extended training season in elite rowers. Metabolism 2006, 55: 13-9. (Pubitemid 41736241)
23. Jürimäe J, Purge P, Jürimäe T. Effect of prolonged training period on plasma adiponectin in elite male rowers. Horm Metab Res 2007, 39: 519-23. (Pubitemid 47204197)
24. Jürimäe J, Jürimäe T, Ring-Dimitriou S, LeMura LM, Arciero PJ, von Duvillard SP. Plasma adiponectin and insulin sensitivity in overweight and normal-weight middle-aged premenopausal women. Metabolism 2009, 58: 638-43.